No abstract

Using survey methodology we examined the relationships between commitment to moral selfimprovement (CMSI), religiosity, ethical problem recognition, and behavioral intentions in a sample of 242 business students. Results of the study suggest that CMSI predicts ethical problem recognition and behavioral intentions. Our findings also suggest that CMSI is positively related to religiosity. The study provides some evidence of CMSI being a mediator in the influence of religiosity on ethical problem recognition and behavioral intentions. Compared to religiosity, CMSI turned out to be a better predictor of perceived importance of ethics, ethical problem recognition, and ethical behavioral intentions. The results of the study have implications for increasing understanding of ethical decision-making, future studies of business ethics, and business ethics education.

No abstract

Background: Genetics research is not routinely disseminated into gastroenterology clinical practice, thereby missing opportunities to identify hereditary cancer syndromes. Aim: To identify effectiveness outcomes of a nurse practitionereled cancer genetics program. Methods: The Donabedian model was used to identify program effectiveness outcomes. A screening tool was administered to 10,324 patients. Conclusions: Pathogenic variant carriers were identified in 35% of patients tested. Program screening and surveillance met effectiveness outcomes criteria; tumor testing as a method of screening did not. Nurse practitionereled cancer genetics programs integrate evidence-based guidelines and provide person-centered care to enhance quality care outcomes.

The purpose of the current project was to assess missed opportunities to identify metabolic syndrome in patients treated with second-generation antipsychotic medication in a community hospital's inpatient psychiatric unit between January 1 and December 31, 2020. Data on demographics, metabolic syndrome risk factors, body mass index, medications, related diagnoses, and primary care providers (PCPs) were collected via retrospective chart review of 194 patients. This project used a nonexperimental design and heterogenous nonrandom convenience sample. Descriptive statistics, chi-square tests, one-tailed t tests, and binary logistic regression were used. The overall rate of metabolic syndrome was 47.4% ( n = 92). A positive PCP status was significant for treatment with antihypertensives, statins, and antihyperglycemics ( p < 0.05). Findings indicate the need to increase system-wide assessment of metabolic syndrome and integrate care coordination with PCPs. [ Journal of Psychosocial Nursing and Mental Health Services, 60 (8), 11–18.]